Advanced search×

Prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis of maintenance proton pump inhibition.

Am J Med 102(1):78-88 (1997) PMID 9209204

To determine the cost-effectiveness of three management strategies for healed erosive reflux esophagitis: maintenance therapy with a proton pump inhibitor (PPI) from the outset; no maintenance therapy unless a patient's symptoms recur once over a year; and no maintenance therapy unless a patient's symptoms recur twice over a year.

DOI: 10.1016/S0002-9343(96)00301-4
Version: za2963e q8za2 q8zba q8zc9 q8zd0 q8ze4 q8zfe q8zg7

Similar articles you may find interesting…

  1. Economic evaluation of palivizumab in children with congenital heart disease: a Canadian perspective.

    Can J Cardiol 27(4):523.e11-5 (2011) PMID 21664100

    Palivizumab is clinically effective; however, the cost was exceptionally high relative to the outcomes in this population. Given the financial constraints in a public health care setting, more strict criteria for patient selection or reduced drug costs would improve the cost-effectiveness of RSV pro...
  2. [Cost-effectiveness of the treatment of reflux esophagitis: proton pump inhibitor versus histamine-2-receptor antagonist].

    Nihon Rinsho 58(9):1881-5 (2000) PMID 11004820

    We also recommend that prescription of PPIs for a one-month period be approved by the Japanese health insurance scheme....
  3. [Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor ve...

    Nihon Rinsho 62(8):1504-9 (2004) PMID 15344541

    GERD is a common condition and acid-suppressing agents are the mainstay of treatment. A cost-effectiveness analysis comparing a PPI, lansoprazole (LPZ) and a H2RA, famotidine (FAM) for the maintenance treatment of reflux esophagitis in Japan was performed using a Markov chain approach. The time perio...